COPD: Concomitant Treatment With Nebulized Formoterol Fumarate & Tio - Significant Improvements

A newly published study presents data demonstrating that patients with Chronic Obstructive Pulmonary Disease (COPD), including emphysema and chronic bronchitis, experienced markedly improved bronchodilation and symptom control when treated with a combination of nebulized formoterol fumarate inhalation solution (Perforomist? Inhalation Solution) and tiotropium (TIO), compared to treatment with tiotropium alone.

More: continued here

Filed under: Clinical Trials on May 22nd, 2008